Expression of MECOM is associated with unfavorable prognosis in glioblastoma multiforme.

Hou, Aiwu; Zhao, Lizhen; Zhao, Fuzhen; Wang, Weiliang; Niu, Jianyi; Li, Bingxuan; Zhou, Zhongjin; Zhu, Dongyuan

Hou, Aiwu; Zhao, Lizhen; Zhao, Fuzhen; Wang, Weiliang; Niu, Jianyi; Li, Bingxuan; Zhou, Zhongjin; Zhu, Dongyuan.

Afiliação

Hou A; Department of Neurology, Yidu Central Hospital of Weifang City.
Zhao L; Department of Neurology, Yidu Central Hospital of Weifang City.
Zhao F; Department of Orthopedics, People's Hospital of Qingzhou City.
Wang W; Department of Psychiatrics, People's Third Hospital of Weifang City, Weifang.
Niu J; Department of Neurology, Yidu Central Hospital of Weifang City.
Li B; Department of Neurology, Yidu Central Hospital of Weifang City.
Zhou Z; Department of Neurology, Yidu Central Hospital of Weifang City.
Zhu D; Department of Medical Oncology, Shandong Cancer Hospital and Institute, Shandong Academy of Medical Sciences.

Onco Targets Ther ; 9: 315-20, 2016.

Article em En | MEDLINE | ID: mdl-26834490

Palavras-chave

MECOM; glioblastoma multiforme; prognosis; progression

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Onco Targets Ther Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google